SciSparc (SPRC) Change in Receivables (2016 - 2018)
SciSparc (SPRC) posted Change in Receivables of $183000.0 for Q4 2018, up 296.77% sequentially from -$93000.0 in Q3 2018, and up 315.29% YoY from $44065.2 in Q4 2017.
SciSparc (SPRC) Change in Receivables (2016 - 2018) Analysis & Trends
SciSparc has reported Change in Receivables for 3 years, with the latest figure at $183000.0 in Q4 2018.
- Quarterly Change in Receivables rose 315.29% year-over-year to $183000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$99000.0 (up 30.77% YoY) and the FY2025 annual result came in at $790000.0, up 247.66% from the prior year.
- Change in Receivables climbed to $183000.0 in Q4 2018 per SPRC's latest filing, from -$93000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $183000.0 in Q4 2018 and troughed at -$139000.0 in Q1 2018.
- A 3-year average of -$35181.8 and a median of -$50000.0 in 2018 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 315.29% in 2018, down 1637.5% in 2018.
- Over 3 years, Change in Receivables stood at -$125000.0 in 2016, then soared by 32.0% to -$85000.0 in 2017, then soared by 315.29% to $183000.0 in 2018.
- According to Business Quant data, Change in Receivables over the past three periods registered $183000.0, -$93000.0, and -$50000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 183,000.00 |
| Dec 31, 2018 | 183,000.00 |
| Sep 30, 2018 | -93,000.00 |
| Sep 30, 2018 | -93,000.00 |
| Jun 30, 2018 | -50,000.00 |
| Jun 30, 2018 | -50,000.00 |
| Mar 31, 2018 | -139,000.00 |
| Mar 31, 2018 | -139,000.00 |
| Dec 31, 2017 | -85,000.00 |
| Dec 31, 2017 | -85,000.00 |
| Sep 30, 2017 | 52,000.00 |
| Sep 30, 2017 | 52,000.00 |
| Jun 30, 2017 | -102,000.00 |
| Jun 30, 2017 | -102,000.00 |
| Mar 31, 2017 | -8,000.00 |
| Mar 31, 2017 | -8,000.00 |
| Dec 31, 2016 | -125,000.00 |
| Dec 31, 2016 | -125,000.00 |
| Sep 30, 2016 | 22,000.00 |
| Sep 30, 2016 | 22,000.00 |